Haloperidol administration in humans lowers plasma nerve growth factor level: Evidence that sedation induces opposite effects to arousal

Neuropsychobiology

Volumn 36, Issue 2, 1997, Pages 65-68

  Aloe, Luigi ^a   Iannitelli, Angela ^b   Bersani, Giuseppe ^b   Alleva, Enrico ^c   Angelucci, Francesco ^a   Maselli, Paolo ^b   Manni, Luigi ^a  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Arousal; Haloperidol; Nerve growth factor; Schizophrenia; Sedation

Indexed keywords

HALOPERIDOL; NERVE GROWTH FACTOR; NEUROLEPTIC AGENT;

ADULT; AROUSAL; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; COPING BEHAVIOR; EMOTIONAL STRESS; HUMAN; HYPOTHALAMUS; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AROUSAL; CATALEPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HALOPERIDOL; HUMANS; MALE; NERVE GROWTH FACTORS; SCHIZOPHRENIA;

EID: 0030798870     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119364     Document Type: Article

References (30)

1. Levi-Montaleini R: The nerve growth factor: Thirty-five years later, Science 1987;237: 1154-1162.
2. Whittemore SR, Seiger A: The expression, localization and functional significance of nerve growth factor in the central nervous system, Brain Res Rev 1987;12:439-464.
3. Thoenen H, Bandtlow C, Heumann R: The physiological function of nerve growth factor in the central nervous system: Comparison with the periphery, Rev Physiol Biochem Pharmacol 1987:109:146-171.
4. Levi-Montalcini R, Aloe L, Alieva E: A role for nerve growth factor in nervous, endocrine and immune systems, Prog Neuroendocrinol Immun 1990:3:1-10.
5. Aloe L, Skaper SD, Leon A, Levi-Montalcini R: Nerve growth factor and autoimmune disease, Autoimmunity 1994:19:141-150.
6. Aloe L, Alieva E, Bohm A, Levi-Montaleini R: Aggressive behaviour induces release of nerve growth factor from mouse salivary gland into the bloodstream, Proc Natl Acad Sci USA 1986;83:6184-6187.
7. Luppi P, Levi-Montaleini R, Bracci-Laudiero L, Bcrtolini A, Arletti R, Tavemari D, Aloe L: NGF is released into plasma during human pregnancy: An oxytocin-mediated response? Neuroreport 1993;4:1063-1065.
8. Maestripieri D, De Simone R, Aloe L, Alieva E: Social status and nerve growth factor serum levels after agonistic encounters in mice, Physiol Behav 1990;47:61-64.
9. Aloe L, Bracci-Laudiero L, Alieva E, Lambiase A, Micera A, Tirassa P: Emotional stress induced by parachute jumping enhances blood NGF levels and the distribution of NGF-recep-tors in lymphocytes, Proc Natl Acad Sci USA 1994;91:10444-10447.
10. Aloe L, Tuveri MA, Guerra G, Pinna L, Tirassa P, Micera A, Alieva E: Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal, Alcohol Clin Exp Res 1996;20:462-465.
11. Yntema O, Korf P: Transient suppression by stress of haloperidol-induced catalepsy by the activation of the adrenal medulla, Psychopharmacology 1987.91:131-134.
12. Fox C, Mansour A, Watson SJ: The effect of haloperidol on dopamine receptor gene expression, Exp Neurol 1994:130:288-303.
13. Grantham CJ, Main MJ, Cannell MB: Fluspiri-lene block of N-type calcium current in NGF-diffcrcntiated PC 12 cells, Br J Pharmacol 1994;111:483-488.
14. Chopde CD, Hole MS, Mandhane SN, Mu-thual AV: Glucocorticoids attenuate haloperidol-induced catalepsy through adrenal catecholamines, J Neural Transrn 1995; 102:47-54.
15. Alieva E, Della Seta D, Cirulli F, Aloe L: Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice, Prog Psychopharmacol Biol Psychiatry 1996; 20:483-489.
16. Alberch J, Brito B, Notario V, Castro R: Prenatal haloperidol treatment decreases nerve growth factor receptor and mRNA in neonate rat forebrain, Neurosci Lett 1991:131:228-232.
17. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, American Psychiatric Association, 1987.
18. Bracci-Laudiero L, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen S, Otten U: Multiple sclerosis patients express increased levels of P-NGF factor in cerebrospinal fluid, Neurosci Lett 1992;147:9-12.
19. Banerjee SP, Zuck LG, Yablonsky-Alter E, LidskyTl: Glutamate agonist activity: Implications for antipsychotic drug action and schizophrenia, Neurorcport 1995;6:2500-2504.
20. Bersani G, Aloe L, lannitelli A, Masclli P, Alieva E, Angelucci F, Pancheri P: Nerve growth factor (NGF) plasma levels in schizophrenic patients: Preliminary results, Biol Psychiatry, submitted.
21. Heisenberg CP, Cooper JD, Berke J, Sofronicw MV: NMDA potentiates NGF-induced sprouting of septal cholinergic fibres, Neuroreport 1994:5:413-416.
22. Frim DM, Yee WM, Isacson O: NGF reduces striatal cxcitotoxic neuronal loss without affecting concurrent neuronal stress, Neuroreport 1993;4:655-658.
23. Knipper M, Leung LS, Zhao D, Rylett RJ: Short-term modulation of glutamalergic synapses in adult rat hippocampus by NGF, Neuro-report 1994;5:2433-2436.
24. Aloe L: Adrenalectomy decreases nerve growth factor in young adult rat hippocampus, Proc Natl Acad Sci USA 1989:86:5636-5640.
25. Nemcoff CB: The role of corticotropin-releasing factor in the pathogenesis of major depression, Pharmacopsychiatry 1988:21:76-82.
26. Otten U, Baumann JB, Girard J: Stimulation of the pituitary-adrenocortical axis by nerve growth factor, Nature 1979:282:413-414.
27. Nanko S, Hattori M, Kuwata S, Sasaki T, Fukuda R, Dai XY, Yamaguchi K, Shibata Y, Kazamatsuri H: Neurotrophin-3 gene polymorphism associated with schizophrenia, Acta PsychiatrScand 1994;89:390-392.
28. Emfors P, Ibanez CF, Ebendal T, Olson L, Pearsson H: Molecular cloning and ncuro-trophic activities of a protein with structural similarities to nerve growth factor: Development and topographical expression in the brain, Proc Natl Acad Sci USA 1990:87:5454-5458.
29. Friden PM, Walus LR, Watson P, Doctrow SR, Kozarich JW, Backman C, Bergman H, Hoffcr B, Bloom F, Granholim AC: Blood brain barrier penetration and in vivo activity of an NGF conjugate, Science 1993;259:373-379.
30. Gold JM, Weinberger DR: Cognitive deficits and the neurobiology of schizophrenia, Curr Opin Neurobiol 1995;5:225-230.